Prevention of Premature Death of Somatic Causes in Patients with Mental Illness and Comorbid Substance Use Disorder

被引:0
|
作者
Kynde, A. [1 ]
机构
[1] Aarhus Univ Hosp Risskov, Organ Disorders & Emergency Ward M, Risskov, Denmark
关键词
D O I
10.1016/S0924-9338(15)30142-5
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
0176
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Family intervention for severe mental illness and substance use disorder
    Mueser, KT
    Fox, L
    Mercer, C
    NEW FAMILY INTERVENTIONS AND ASSOCIATED RESEARCH IN PSYCHIATRIC DISORDERS, 2002, : 205 - 227
  • [22] Sex Differences in Comorbid Mental and Substance Use Disorders Among Primary Care Patients With Opioid Use Disorder
    Braciszewski, Jordan M.
    Idu, Abisola E.
    Yarborough, Bobbi Jo H.
    Stumbo, Scott P.
    Bobb, Jennifer F.
    Bradley, Katharine A.
    Rossom, Rebecca C.
    Murphy, Mark T.
    Binswanger, Ingrid A.
    Campbell, Cynthia, I
    Glass, Joseph E.
    Matson, Theresa E.
    Lapham, Gwen T.
    Loree, Amy M.
    Barbosa-Leiker, Celestina
    Hatch, Mary A.
    Tsui, Judith, I
    Arnsten, Julia H.
    Stotts, Angela
    Horigian, Viviana
    Hutcheson, Rebecca
    Bart, Gavin
    Saxon, Andrew J.
    Thakral, Manu
    Grant, Deborah Ling
    Pflugeisen, Chaya Mangel
    Usaga, Ingrid
    Madziwa, Lawrence T.
    Silva, Angela
    Boudreau, Denise M.
    PSYCHIATRIC SERVICES, 2022, 73 (12) : 1330 - 1337
  • [23] Subjects affected by a substance use disorder with or without a comorbid mental disorder: Looking for differential factors
    Mateu-Codina, G.
    Fonseca-Casals, F.
    Gratacos-Mayora, M.
    Martin-Santos, R.
    Sauras-Quetcuti, R.
    Farre-Martinez, A.
    Diaz-Digon, L.
    Castillo-Buenaventura, C.
    Torrens-Melich, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S174 - S175
  • [24] Criminal history in a group of patients with co-occurrence of mental illness and substance use disorder
    Mateu Codina, G. A.
    Garcia-Fuentes, D.
    Sauras-Quetcuti, R. B.
    Coratu, A. M.
    Oviedo-Penuela, L. M.
    Garcia-Guix, A.
    Marti-Bonany, J.
    Sanchez-Gonzalez, R.
    Hurtado-Ruiz, M. G.
    Carrio-Diez, E.
    Castillo-Buenaventura, C.
    Fonseca, M. F.
    Torrens, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 53 : S10 - S11
  • [25] Cost Offsets of Treatment for Serious Mental Illness and Substance Use Disorder
    Henke, Rachel Mosher
    Head, Michael A.
    Camacho-Cook, Jessica
    Lin, Janice R.
    Carroll, Christopher D.
    PSYCHIATRIC SERVICES, 2021, 72 (09) : 1006 - 1011
  • [26] Remission of substance use disorder among psychiatric inpatients with mental illness
    Dixon, L
    McNary, S
    Lehman, AF
    AMERICAN JOURNAL OF PSYCHIATRY, 1998, 155 (02): : 239 - 243
  • [27] PREMATURE DEATH IN MENTAL ILLNESS Smoking cessation is a priority in psychiatric patients
    Rashid, M. Ahmed
    BMJ-BRITISH MEDICAL JOURNAL, 2013, 346
  • [28] Clinical specificities of patients with substance use disorder and comorbid borderline personality disorder compared to patients with substance use disorder only: a retrospective study
    Blay, Martin
    Verne, Manon
    Durpoix, Amaury
    Benmakhlouf, Ines
    Labaume, Laura
    JOURNAL OF ADDICTIVE DISEASES, 2024,
  • [29] Premature death among people with mental illness
    Thornicroft, Graham
    BMJ-BRITISH MEDICAL JOURNAL, 2013, 346
  • [30] Clozapine use in patients with schizophrenia and a comorbid substance use disorder: A systematic review
    Arranz, Belen
    Garriga, Marina
    Garcia-Rizo, Clemente
    San, Luis
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2018, 28 (02) : 227 - 242